Provided by Tiger Trade Technology Pte. Ltd.

Bolt Biotherapeutics, Inc.

3.67
+0.465014.53%
Post-market: 3.670.0025+0.07%19:14 EDT
Volume:65.25K
Turnover:228.12K
Market Cap:7.03M
PE:-0.22
High:3.78
Open:3.24
Low:3.20
Close:3.20
52wk High:7.20
52wk Low:3.13
Shares:1.92M
Float Shares:1.44M
Volume Ratio:3.59
T/O Rate:4.53%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-16.3353
EPS(LYR):-17.8500
ROE:-111.65%
ROA:-30.73%
PB:0.56
PE(LYR):-0.21

Loading ...

Bolt Biotherapeutics, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 12

Aardvark Therapeutics Q2 Operating Expenses Fall on Paused ARD-101 Clinical Trials and Workforce Reduction

Reuters
·
Aug 12

Bolt Biotherapeutics Q2 Net Loss Narrows on Restructuring and Lower Research Activity

Reuters
·
Aug 12

Bolt Biotherapeutics Q2 EPS $(4.57) Misses $(2.88) Estimate, Sales $5.000K Miss $500.000K Estimate

Benzinga Earnings
·
Aug 12

Bolt Biotherapeutics Rugi Bersih Q2 FY26 Menyempit 9,82% Menjadi USD 7,72 Juta

Reuters
·
Aug 12

Bolt Biotherapeutics, Inc. Q2 Collaboration Revenue USD 5 Thousand

THOMSON REUTERS
·
Aug 12

Bolt Biotherapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

GlobeNewswire
·
Aug 12

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Aug 11

Bolt Biotherapeutics, Inc. Expected to Post a Loss of $3.39 a Share - Earnings Preview

Reuters
·
Aug 10

Analysts Offer Insights on Healthcare Companies: Aquestive Therapeutics (AQST), Revolution Medicines (RVMD) and Bolt Biotherapeutics (BOLT)

TIPRANKS
·
Jun 25

Bolt Biotherapeutics Holds 2026 Annual Stockholder Meeting

TIPRANKS
·
Jun 12

Bolt Biotherapeutics shareholders elect Quinn, Dupont to board class II seats

Reuters
·
Jun 12

BRIEF-Bolt, Pony.Ai, Stellantis To Launch Autonomous Mobility Testing Program In Luxembourg

Reuters
·
Jun 09

Bolt, Stellantis, Pony.ai to launch autonomous vehicle test program in Luxembourg

Reuters
·
Jun 09

Bolt Biotherapeutics Initiated at Buy by Rodman & Renshaw

Dow Jones
·
May 29

Bolt Biotherapeutics initiated with a Buy at Rodman & Renshaw

TIPRANKS
·
May 29

Bolt Biotherapeutics Price Target Maintained With a $7.00/Share by HC Wainwright & Co.

Dow Jones
·
May 28

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
May 28

Analysts Have Conflicting Sentiments on These Healthcare Companies: Bolt Biotherapeutics (BOLT) and Upstream Bio, Inc. (UPB)

TIPRANKS
·
May 14

Bolt Biotherapeutics Q1 EPS $(4.31) Misses $(2.85) Estimate, Sales $26.000K Miss $1.500M Estimate

Benzinga Earnings
·
May 13